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ABSTRACT
Objective: The objective of the study was to evaluate the antinociceptive effect of Raphanus sativus Linn. using Randall Selitto method.
Methods: Streptozotocin, lard, casein, cholesterol, DL-methionine, yeast powder, quercetin, thiobarbituric acid, 2-nitrobenzoic acid (5, 5, Dithiobis), 
hematoxylin, and hydrogen peroxide were used. A diet rich in fat content was fed to the animals for a period of 2 weeks. After a stabilization period of 
2 weeks, the treatment period started and continued for a period of 8 weeks. The nociceptive parameters were assessed once a week by Randall Selitto 
method and hot plate test. After treatment, the animals were sacrificed, and antioxidant parameters were assessed using sciatic nerve homogenate 
and histopathological analysis of sciatic nerve.
Results: Treatment R. sativus extract (RSE 100 mg/kg and 200 mg/kg) appreciably declined the levels of blood glucose in a dose-dependent manner, 
and it was comparable with standard quercetin. A significant increase in pain threshold levels was observed by the treatment RSE in hot plate method 
after the 4th week compared to diabetic control, and it was consistent until the end of treatment (p<0.01, p<0.001). In Randall Selitto method RSE 
produced a significant increase in paw withdrawal threshold after the 4th week compared to diabetic control, and it was consistently increased until 
the end of treatment. RSE (100 and 200 mg/kg) significantly restored the levels of antioxidant enzymes and decreased lipid peroxidation in a dose-
dependent fashion in comparison with the diabetic control group. RSE (100 mg/kg and 200 mg/kg) attenuated the nerve degeneration and axonal 
swelling along with quercetin.
Conclusion: The findings from the current study showed the antinociceptive and antioxidant effect of R. sativus in neuropathic pain in diabetes.
Keywords: Raphanus sativus Linn., Streptozotocin, Type II diabetes mellitus, Sciatic nerve, Antinociceptive effect, Randall Selitto method.
INTRODUCTION
Plant contemplates as one of the most important sources for developing 
a synthetic molecule in new drug development and discovery. In ancient 
histories, traditional remedies of herbal medication were preferred for 
treating people with acute and chronic illness. Raphanus sativus (RS) Linn. is 
considered as one of them. It belongs to the family Brassicaceae commonly 
known as a radish. It is being widely cultivated all over the country, 
mainly in China and Mediterranean countries for almost 1000 years. 
The leaves, seeds, and roots of RS Linn. are used as antirheumatic, 
analgesic, antiarthritic, hepatotropic, antifungal, antioxidative, anti-HIV, 
antineoplastic, and choleretic [1]. In Churu Rajasthan, this is getting 
used traditionally for the treatment of rheumatism, diarrhea, asthma, 
and piles [2]. In various parts of India, the extract of RS Linn. is being 
used for constipation [3]. It has various chemical constituents such as 
isothiocyanate, myrosinase, and glucasinolate are produced by this 
plant. The ethanolic extract showed higher activity and dose-dependent 
scavenging of free radical than methanolic and water extracts in vitro 
[4]. RS Linn. proven to have antioxidants, phytotoxins, antibacterial, anti-
inflammatory, and free radical scavenging properties and its also being 
used as companion plant because it repels the pest and insect due to its 
pungent odor [5]. RS Linn. contains Vitamin C, carotenoids, flavonoids, 
and fibers and also a group of health-promoting metabolites called 
glucosinolates. Therefore, consumption of Brassicaceae vegetables may 
prevent the risk of cancer and reduces the inflammation response. This 
research aimed to investigate and justify the antinociceptive potential of 
RS Linn. using a high-fat diet (HFD) and Streptozotocin (STZ) (low dose)-
induced diabetic neuropathy in rats [6]. Type 2 diabetes is a progressive 
disease characterized by hyperglycemia with insulin resistance in early 
condition [7]. Nerve damage gets developed all around the body of a 
METHODS
Plant material
The fresh leaves of R S Linn. collected from local markets of interior 
villages of Bhubaneswar, Odisha during August 2018. Identified and 
authenticated by Professor Dr. D.P Ray of Regional Plant Resource 
Centre Bhubaneswar, Odisha, bearing accession number (PN/01). The 
collected leaves were shade dried and converted to powder with the 
help of mixer grinder. The collected powder was accurately weighed 
and kept in a well-closed airtight container [1,15].
Animals
Healthy, male adult Wistar rats (150–250 g) were issued from SOA 
Deemed to be University animal house, Bhubaneswar, Odisha. The 
animals were kept under the appropriate condition as mentioned in 
CPCSEA guidelines. The animals were maintained with palate diet and 
potable drinking water, provided by the institution. Experimentation 
was conducted after obtaining prior approval of IAEC (Approval no. 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.31003
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patient  suffering  from  type  2  diabetes  mellitus  (DM)  over  a  long 
period  of  time.  Neuropathies  can  be  peripheral,  focal,  and 
proximal  in  type.  Associated  with  varying  symptoms  like 
numbness,  tingling  sensation,  pain  in  feet’s,  toes  and  arms  and 
muscular wasting which causes ample discomfort to a patient [8-11].
 The often chosen pathway for chemical induction of type 2 diabetes 
in rats is through STZ. The long-term elevated glucose level in the blood is 
easy  to  cause  a  variety  of  diabetic  complication  such  as  neuropathy, 
nephropathy,  cardiopathy,  and  retinopathy  [12].  Due  to  its  cytotoxic 
action  on  pancreatic  β-  cell,  hyperglycemia  is  manifested.  Due  to  its 
reproducibility;  STZ  is  the  first  line  choice  for  inducing  diabetes 
chemically [13,14].
530
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 529-534
 Sahoo and Panda 
SOA/SPS/IAEC/2018/07) under the School of Pharmaceutical Sciences, 
SOA Deemed to be University, Bhubaneswar, Odisha.
Chemicals
The chemicals STZ, metformin, and quercetin, were obtained from S 
D Fine-chemicals Mumbai, India. All other chemicals, solvents, and 
reagents used were obtained from the Department of Pharmacology 
from the School of Pharmaceutical Sciences, Siksha O Anusandhan 
(Deemed to be University), Bhubaneswar, Odisha.
Preparation of extract
Step involved in the extraction of crude drugs
• Suitable size reduction of dried plant material.
• Extraction by the process of continuous hot percolation or Soxhlet 
apparatus using 70% ethanol.
• Removal of the solvent to obtain the extract.
Process
The shade dried leaves were further dried at 25°C for 3 days. These 
dried leaves were exposed to grinding and given to a form of coarse 
powder. These powders were transferred and extracted using 70% 
ethanol for 1 day. The extract obtained was dried in a water bath at 
70°C. The product obtained was stored in desiccators. The extracted 
yield percentage was calculated as mentioned below.
% yield = weight of extract/weight of powder ×100
= 86/270 × 100
= 31.8%
The required amount of extract was dissolved in sterile water and used 
for in vivo pharmacological studies.
Development of type 2 DM in rats using STZ and HFD [16-18]
For a period of 2 weeks, the HFD was administered to the animals. The 
constituents of the fat diet were given below. After completion of the 
above said time, the induction of diabetes was done by intraperitoneal 
injection of STZ (35 mg/kg body weight). The blood glucose levels 
were further monitored with the help of one touched glucometer. 
Those animals exhibiting the level of blood glucose >300 mg/dl were 
considered for further pharmacological analysis.
The composition of a HFD
S. No. Constituents Diet g/kg





6 Powdered yeast 01
7 NaCl 01
Treatment schedule
The basal recording of nociception reaction was noted and the animals 
were grouped in the following manner and exposed to further treatment 
for 8 weeks.
• Group I - Normal control
• Group II - Diabetic control
• Group III - Diabetic + RS extract (RSE) (100 mg/kg)
• Group IV - Diabetic + RSE (200 mg/kg)
• Group V - Diabetic + Quercetin (100 mg/kg)
The parameters measured during the drug treatment are blood glucose 
levels (single and multiple dose study); antinociceptive parameters (hot 
plate method and Randall Selitto method) were measured once in a week for 
8 weeks. After 8 weeks, the treated animals were euthanized and sacrificed, 
and the sciatic nerve was removed to assess antioxidant parameters.
Experimental design
Measurement of blood glucose level [19]
The rats were administered with a single dose of respective test and 
standard drugs; the plasma glucose level was measured before drug 
administration at 1, 2, and 4 h. In a multiple-dose study for a duration of 
11 days, the animals were treated with the same dose and monitoring 
the level of blood glucose was done on 3rd, 5th, 7th, 9th, and 11th days.
Measurement of antinociceptive activity
The antinociceptive activity was assessed every week during the 
treatment period, and it was carried out for 8 weeks. The antinociceptive 
activity was measured using the following methods.
Hot plate method [20]
The hot plate was stabilized at 52°C±0.5°C. The individual animal was placed 
on the surface of the hot plate for a time period until response such as paw 
licking or jumping has appeared. 20 s cutoff time was maintained to abstain 
from any injury to rat paw. This method served as an index of pain threshold.
Randall Selitto mechanical hyperalgesia test [11,21]
This method was used for measuring antinociceptive activity it was carried 
out by applying pressure on hind paw and measuring the threshold of foot 
withdrawal using Ugo Basile Analgesy-meter. The dorsal surface of the rat 
Fig. 1: Control
Fig. 2: Diabetic control
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paw was kept under the domed shaped plastic tip. The instrument linearly 
increases the mechanical force on the rat paw with the help of the tip and 
this force was applied until the withdrawal of paw was seen.
Antioxidant parameters
After the treatment period for 8 weeks, rats were killed by cervical 
dislocation, sciatic nerve carefully exposed, and dissected. The sciatic 
nerve was homogenized with 1 ml ice-cold sodium phosphate 0.1 mol/l 
buffer having pH 6.5. The obtained homogenates were subjected 
to centrifugation at 20,000 rpm, and the obtained supernatant was 
subjected for further assays of activity of the following enzymes.
Estimation of malondialdehyde (lipid peroxidation) [22]
Tris buffer 0.5 ml and 0.5 ml of supernatant fraction was subjected to 
incubation for 2 h at 37°C. After the addition of trichloroacetic acid 
(01 ml), centrifugation was done for 10 min at 1000 rpm. To 1 ml of 
supernatant fraction 0.67%, thiobarbituric acid was added. For about 
10 min, the tubes were kept in boiling water, and then the tubes were 
allowed to cool followed by which 1 ml of distilled water addition was 
done, and its absorbance got measured at 532 nm. Quantification of 
thiobarbituric acid derivatives was done using extinction coefficient 
and got expressed as n mole of malondialdehyde per mg protein 
1.56 × 105 M−1 cm−1.
Estimation of glutathione (reduced) (GSH) [19]
Precipitation of 1 ml of the supernatant was done with 1 mL of 
trichloroacetic acid (10%). For 1 h, the sample was maintained at 4°C 
and further centrifuged at 1200 rpm for a duration of 15 min at 4°C. The 
assay mixture contained 2.7 ml phosphate buffer (0.1 M, pH 7.4), 0.2 ml 5, 
5, dithiobis (2-nitrobenzoic acid) (Ellman’s reagent, and 0.1 mM, pH 8.0) 
was given to total volume of 3.0 ml. The absorbance got measured at 
412 nm, and the concentration of GSH was expressed as µg/mg.
Estimation of superoxide dismutase (SOD) [23]
The activity of SOD got measured using hematoxylin auto-oxidation 
method. The assay mixture contained phosphate buffer (50 mm), 
0.1 mm EDTA. 2 ml of this mixture was placed in a cuvette and 0.05 ml 
of supernatant, hematoxylin got added to it hematoxylin auto-oxidation 
inhibition was measured at 560 nm using UV-visible spectrophotometry. 
Enzymatic activity was expressed as U/mg of protein.
Estimation of catalase [24]
Assay mixture consisted of phosphate buffer (50 mmol/1 ml), 0.9 ml of 
hydrogen peroxide and 0.1 ml of supernatant fraction (10%) were given 
to the final volume of 3 ml. The absorbance got measured at 240 nm. 
Enzymatic activity was calculated by molar extinction coefficient 
2.04 mmol/l, and enzyme activity was expressed as U/mg protein.
Histopathological studies [17]
The dissected sciatic nerve was preserved in formalin (10%) and 
sliced into 4 μm thickness. Hematoxylin and eosin were used for 
staining. T.S of nerve was qualitatively analyzed under high-resolution 
research binocular microscope (×100) for fiber derangement, axonal 
degeneration, and axonal swelling.
Statistical analysis
The results were expressed in the form of mean± standard deviation 
(SD), and statistics for biochemical parameters were done using ANOVA 
(one-way) followed by Turkey’s multiple comparison tests. Behavioral 
parameters were expressed using ANOVA (two way) used followed by 
Bonferroni post-test, using GraphPad Prism version 5 software.
RESULTS
The activity of RS Linn. on levels of blood glucose (single and 
multiple dose analysis)
STZ-treated animals reflected marked elevation in the level of blood 
sugar in comparison to normal control rats (p<0.001). Treatment with 
RSE (100 mg/kg and 200 mg/kg) elicited steep fall in levels of blood 
glucose after 2 h. RSE (100 mg/kg) reflected 11.67% reduction in levels 
of blood glucose after 4 h whereas RSE (200 mg/kg) showed 14.52% 
reduction and a thereafter slight increase in blood levels was observed 
in comparison to standard drug. The changes in blood glucose levels 
were given in Table 1.
Fig. 3: Quercetin (100 mg/kg)
Fig. 4: Raphanus sativus extract (100 mg/kg)
Fig. 5: Raphanus sativus extract (200 mg/kg)
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using RSE (100 mg/kg and 200 mg/kg) and quercetin for a period 
of 8 weeks significantly lowered the MDA levels in dose-dependent 
fashion (p<0.001, p<0.01).
Significantly lower levels of antioxidant enzymes peroxidase and 
dismutase were seen in diabetic rats in comparison with normal control 
rats (p<0.001). Treatment with RSE (100 mg/kg and 200 mg/kg) and 
quercetin remarkably increases the levels of catalase, SOD and GSH 
(p<0.001, p<0.01) and thereby restoring the levels to normal. The 
effect of RSE was found to be in a dose-dependent fashion. Changes in 




1 Control A normal architecture nerve fiber is seen 
with no degenerative fibers
2 Diabetic control Extensive derangement of nerve fibers, 
axonal degeneration, and swelling
3 Quercetin  
(100 mg/kg) 
treated group
Moderate fiber derangement with axonal 
degeneration
4 RSE  
(100 mg/kg) 
treated a group
Extensive derangement of nerve fiber 
with moderate axonal degeneration
5 RSE  
(200 mg/kg) 
treated a group
Fiber derangement with moderate 
axonal degeneration
DISCUSSION
Randal Selitto method has not been used for establishing the 
antinociceptive potential of RS. This plant has widespread cultivation 
in anterior villages of Bhubaneswar, Odisha, so this would serve as 
a suitable and economic alternative for neuropathic complications 
associated with diabetic patients. DM is a metabolic complication 
comprising several pathological changes such as hyperglycemia, insulin 
resistance, glucose tolerance, and hypertriglyceridemia. Oxidative 
stress gets induced due to hyperglycemia and results in activation of 
In a multiple-dose study, administration of RSE showed a steep 
decrease in the level of blood glucose from day 3 in a dose-dependent 
manner. RSE (200 mg/kg) showed the highest decline in the level of 
blood glucose between day 9 and day 11 and percentage reduction 
was found to be 17.46–23.64. The changes in blood glucose levels were 
given in Table 2.
Effect of RSE on nociceptive parameters
Hot plate method
The threshold of nociception was very low in diabetes-induced rats 
when compared to basal value tested animals. Hyperalgesia diabetic was 
observed after the 1st week of treatment (p<0.05) and 2nd week (p<0.01) 
and steep reduction in pain threshold was seen after the 3rd week in 
comparison to control animals (p<0.001) and was maintained until 
the termination of the treatment period. Administration of quercetin 
and RSE 200 mg/kg which increases pain threshold in diabetic group 
in comparison to control animals after the 3rd week (p<0.01, p<0.05) 
and RSE 100 mg/kg produced significant effect after the 4th week 
(p<0.01). The highest increase in pain threshold was seen after the 
4th week (p<0.001) for both RSE (200 mg/kg) and quercetin and it was 
maintained until the end of the treatment period. The changes in the 
pain threshold levels were given in Table 3.
Mechanical hyperalgesia test (Randall Selitto method)
The paw withdrawal threshold was reduced to a much greater extent 
as compared to the basal value recorded. Mechanical hyperalgesia was 
evident in diabetic rats after the 2nd week of treatment (p<0.05) and a 
steep decrease in paw withdrawal threshold was seen after the 3rd week 
in comparison with normal control rats (p<0.001) and was maintained 
until the termination of the treatment period. Administration of RSE 
200 mg/kg and quercetin to diabetic group elicited a rise in withdrawal 
threshold in a dose-dependent manner in comparison to control 
animals after the 4th week (p<0.01, p<0.001). Maximum rise in the 
withdrawal threshold was observed after the 5th week (p<0.001) for 
RSE 100 mg/kg and 200 mg/kg and quercetin and it was kept until the 
treatment tenure was over. The changes in the withdrawal threshold 
were given in Table 4.
Effect of RSE on antioxidant parameters using sciatic nerve 
homogenate
Levels of the sciatic nerve (MDA) were remarkably very high in diabetic 
group in comparison to the normal control group (p<0.001). Treatment 
Table 1: Effect of RSE on levels of blood glucose (single dose study)
S. No. Treatment Level of blood glucose (mg/dl)
0 h 1 h 2 h 4 h
1 Normal control 89.33±9.498 89.16±7.543 89.83±6.432 89.16±8.957 
2 Diabetic control 319.33±19.286### 319.12±27.432### 318.23±21.567### 320.18±25.253### 
3 Diabetic+quercetin (100 mg/kg) 317.11±26.764 316.23±24.874 280.33±20.509** 271.5±18.234*** 
4 Diabetic+RSE (100 mg/kg) 327.02±23.952 324.53±19.875 297.16±18.897* 289.66±22.567** 
5 Diabetic+RSE (200 mg/kg) 323.33±23.451 322.51±21.924 281.49±20.675** 276.05±19.243*** 
All value is expressed as mean±SD (n=6). ***p<0.001, **p<0.01, *p<0.05 in comparison to the diabetic control. ###p<0.001 as compared to normal control. (Two-way) 
ANOVA followed by Bonferroni multiple comparison tests. SD: Standard deviation, RSE: Raphanus sativus extract
Table 2: Effect of RSE on levels of blood glucose (multiple dose study)
S. No. Treatment Level of blood glucose (mg/dl)
3rd day 5th day 7th day 9th day 11th day
1 Normal control 84.66±7.952 86.16±5.672 87.33±8.345 85.59±7.925 85.83±9.172 
2 Diabetic control 312.83±21.628### 324.01±24.765### 337.66±29.162### 353.83±31.826### 366.51±33.863### 
3 Diabetic+Quercetin (100 mg/kg) 271.33±19.232** 255.38±20.632*** 231.78±15.824*** 211.03±15.723*** 192.83±13.943*** 
4 Diabetic+RSE (100 mg/kg) 288.16±23.538* 273.02±20.636*** 260.51±18.763*** 239.33±16.935*** 218.82±13.945*** 
5 Diabetic+RSE (200 mg/kg) 275.66±24.874** 263.59±22.873*** 250.51±19.753*** 227.16±20.543*** 210.54±14.534*** 
All value is expressed as mean±SD (n=6). ***p<0.001, **p<0.01, *p<0.05 in comparison to diabetic control. ###p<0.001 as compared to normal control. (Two-way) 
ANOVA followed by Bonferroni multiple comparison tests. SD: Standard deviation, RSE: Raphanus sativus extract
Photomicrographs of sciatic nerve
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CONCLUSION
This study is attempted to investigate the antinociceptive activity of 
RS Linn. using a diet containing high fat and using a lower dosage of STZ 
for inducing diabetic neuropathy in Wistar rats. Randal Selitto a new 
approach for measuring neuropathic pain was used in this research. 
For a period of 14 days, the animals were maintained with diet having 
a high content of fat and then treated with STZ 35 mg/kg to overnight 
fasted rats. The animals were treated for 8 weeks, respectively. The 
levels of blood glucose were further monitored. It was found that steep 
decrease in the level of blood glucose in RSE 100 mg/kg and 200 mg/kg 
in a dose-dependent manner, which can be compared with that of the 
standard drug in both single and multiple dose studies. The nociceptive 
parameters were measured once a week during the treatment period of 
8 weeks. In the hot plate method, it was found that there is a significant 
rise in levels of pain threshold in the RSE in a dose-dependent manner 
and quercetin-treated group when compared to diabetic control. In 
Randall Selitto method, the threshold of paw withdrawal was markedly 
decreased in the diabetic group, which was restored by treatment of RSE 
100 mg/kg and 200 mg/kg in a dose-dependent way as in comparison 
to the standard drug. In vivo oxidative stress was assessed by estimating 
biochemical parameters such as lipid peroxidation, superoxide 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































various biochemical pathways and further leads to advanced glycation 
end  products  formation  on  extracellular  and  intracellular 
circulating  proteins  which  plays  a  key  role  in  the  mediation  of 
secondary  diabetic  complications.  The  rise  in  oxidative  stress 
leads to impairment of vasculature due to endoneurial hypoxia 
which  results  in  abnormal  neuronal  activity,  poor 
neurotrophic support, and reduction in conduction velocity.
 Oxidative stress in diabetes rats causes the generation of
 free radicals that cause endothelial damage to the sciatic 
nerve. The dietary antioxidants improve vascular resistance on 
diabetic  rats  by scavenging reactive oxygen species.  Whereas it  is 
unlimited and easy, access to bodily metabolic, a process in case
 of natural antioxidants and do not possess any sort of side effects. In
 the  current  study,  RSE  showed  a  marked  decrease  in  blood  glucose 
level in the single and multiple dose study, which was consistent with 
reports earlier. DM-induced in rats was done with the help of single 
dose  STZ injection and modified  diet,  which  showed a  diabetic 
state that was similar to type 2 DM in human. Hence, a diet 
with high-fat content and STZ low dose were used to induce type 
2 DM in this study. The most common complication of diabetic 
neuropathy is neuropathic pain, which was the main target of the 
research  we  observed  a  steep  decrease  in  pain  threshold  in 
diabetes-induced rats when compared with normal control,  which 
indicates  thermal  hyperalgesia.  Moreover,  flavonoids  like  rutin  have 
found  to  be  potent  analgesic  and  antidiabetic;  quercetin  has  already 
been  incorporated  in  clinical  trials  for  diabetic  neuropathy.  The 
presence  of  these  flavonoids  may  be  responsible  for 
attenuating diabetic neuropathy pain. Further, it is also reported 
that  there  is  a  (chemical)  structural  similarity  between 
flavonoids  and  cannabinoids;  hence,  they  may  have  direct 
interaction  with  the  cannabinoid  receptors.  Cannabinoids  have 
shown a reduction in pain sensation by acting through brain stem 
circuits,  which  leads  to  pain  suppressing  mechanism as  like  of 
opiates. Treatment with quercetin and RSE significantly increase 
pain threshold in comparison with diabetic rats induced group. 
In  the  present  study,  the  diabetic  group  exhibited  remarkable 
mechanical  hyperalgesia  in  comparison  to  normal  control 
group, which was consistent in earlier reports that state, when 
diabetes is  induced by STZ within a period of  1–8 weeks there is 
the development of mechanical hyperalgesia. Treatment with RSE and
 quercetin  significantly  restored  the  paw  withdrawal  threshold.  The 
actual mechanism, which is held responsible for the decrease 
in  the  level  of  pain  threshold,  has  not  been  completely 
established.  Mechanisms  that  are  postulated  in  leading  to 
neuropathic pain in diabetes are mainly COX activation, oxidative 
stress,  opioidergic,  and  voltage-gated  sodium  channel.  Treatment 
with RSE increases the pain threshold and paw withdrawal pressure,
 which  suggested  the  role  of  oxidative  stress  in  neuropathic  pain 
associated with diabetes.
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Treatment with RSE 100 mg/kg and 200 mg/kg for 8 weeks attenuated 
oxidative stress in diabetic rats, in a dose-dependent fashion. The 
histopathological analysis showed attenuation of axonal degeneration 
and axonal swelling in both RSE 200 mg/kg and quercetin-treated 
groups, which can be compared with that of control and RSE 100 mg/kg 
showed moderate axonal degeneration and axonal swelling. It can be 
concluded that chronic treatment with an ethanolic extract of RS Linn. 
ameliorated the neuropathic pain and oxidative stress along with the 
improvement in blood glucose levels in diabetic rats. The mechanisms 
leading to attenuation of neuropathic pain by RS Linn. may be due to 
anti-hyperglycemic and antioxidant potential.
Thus, RS Linn. will serve as a salutary and therapeutic alternative for 
the control and management of neuropathic pain, commonly linked 
with the patients of DM. Moreover, the research outcome elucidates that 
Randall sellito approach would serve as a better alternative for analysis 
and measurement of neuropathic pain in diabetic rats.
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Table 5: Effect of RSE on in vivo antioxidant parameter using sciatic nerve homogenate
S. No. Treatment Antioxidant parameters
Lipid peroxidation  
(µG/MG protein) 






1 Normal control 1.53±0.091 34.1±4.05 78.3±5.89 0.31±0.04 
2 Diabetic control 4.73±0.128### 8.02±3.35### 37.8±3.49### 0.15±0.0379### 
3 Diabetic+quercetin (100 mg/kg) 2.07±0.120*** 29.2±4.58*** 67.2±6.05*** 0.282±0.028***
4 Diabetic+RSE (100 mg/kg) 3.92±0.138** 18.8±3.97** 50.7±3.67** 0.253±0.047**
5 Diabetic+RSE (200 mg/kg) 2.60±0.153*** 26.7±4.82*** 61.1±4.98*** 0.267±0.0455***
All value is expressed as mean±SD (n=6). ***p<0.001, **p<0.01 in comparison to the diabetic control. ###p<0.001 as compared to normal control. ANOVA (One-way) 
followed by Turkey’s multiple comparison tests. SD: Standard deviation, RSE: Raphanus sativus extract
